<DOC>
	<DOCNO>NCT02431975</DOCNO>
	<brief_summary>The investigator propose non-randomized clinical trial 60 HIV-infected infant identify within 48 hour birth mother investigate consequence early ART establishment maintenance viral reservoir . The first phase ( early ART initiation within 48 hour birth ) examine trajectory i.e . change time viral reservoir detection HIV-specific antibody responses infant test HIV-positive within 48 hour birth initiate early ART . Secondary pathogenesis aim test whether marker neonatal immune quiescence associate extent seed rate decline viral reservoir ART start young age investigate whether marker infant stool sample use non-invasive method define relevant immune HIV-specific parameter associate viral reservoir size . The investigator hypothesize developmental characteristic newborn immunity may make period optimal time begin ART influence seed viral reservoir .</brief_summary>
	<brief_title>Latency Early Neonatal Provision Antiretroviral Drugs Clinical Trial</brief_title>
	<detailed_description>Prevention mother-to-child transmission ( PMTCT ) program use antiretrovirals ( ARVs ) tremendous success sub-Saharan Africa . However , HIV transmission continue occur ( 1 ) implementation PMTCT incomplete ( 2 ) ARV intervention 100 % effective blocking infection . Thus challenge provide treatment HIV-infected child far . The capacity early ART treatment favorably influence viral reservoir potentially lead post-treatment cessation viral control need describe population infant , identify useful public health strategy .</detailed_description>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Lopinavir</mesh_term>
	<mesh_term>Nevirapine</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<criteria>Point care ( POC ) laboratorybased test positive sample collect within 48 hour birth . Mother willing able provide inform consent . Expressed intention leave Johannesburg area permanently . Comorbidities , birth defect condition opinion clinical team great 50 % risk mortality first day life . Comorbidities condition opinion clinical team advise initiation ART within first 48 hour life . Active ( uncontrolled ) maternal psychiatric illness .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>48 Hours</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>HIV</keyword>
	<keyword>infant</keyword>
	<keyword>antiretroviral therapy , highly active</keyword>
	<keyword>antiretroviral agent</keyword>
</DOC>